Steatotic livers for liver transplantation - Life-saving but at a cost: Commentary

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 5, Issue 7, 2008, Pages 360-361

  Feng, Sandy ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR;

ACUTE GRAFT REJECTION; CLINICAL TRIAL; DATA BASE; DISEASE SEVERITY; FATTY LIVER; FOLLOW UP; GRAFT SURVIVAL; HEALTH SURVEY; HEMODIALYSIS; HUMAN; INCIDENCE; ISCHEMIA; KIDNEY FAILURE; LIVER BIOPSY; LIVER GRAFT; LIVER TRANSPLANTATION; MORTALITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECIPIENT; REPERFUSION INJURY; RISK FACTOR; SCORING SYSTEM; SHORT SURVEY;

EID: 47249125702     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep1159     Document Type: Short Survey

References (4)

1. Fishbein TM et al. (1997) Use of livers with microvesicular fat safely expands the donor pool. Transplantation 64: 248-251
2. Nocito A et al. (2006) When is steatosis too much for transplantation? J Hepatol 45: 494-499
3. Verran D et al. (2003) Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Liver Transpl 9:500-505
4. Schaubel DE et al. (2008) The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant 8: 419-425